Perflutren is a diagnostic medication to improve contrast during echocardiograms. When exposed to ultrasound waves, the microspheres resonate and "echo" strong signals back to the ultrasound machine.
- Mechanism
- Curator reviewed
Perflutren is comprised of gas-filled microspheres that are injected or infused into the body. When exposed to ultrasound waves, the microspheres resonate and "echo" strong signals back to the ultrasound machine. The difference in density between the gas-filled bubbles and the blood around them creates an increased level of contrast visible in the resulting ultrasound image. During echocardiography, activated Perflutren enhances images of the inner edges or borders of the heart, producing an improved image that may enable physicians to better diagnose patients.
- Primary indication
- Used as an ultrasound contrast imaging in cardiology and radiology.Curator reviewed · 3 structured indications
- Formula / weight
- C3F8 · 188.0193 g/mol (avg)
- First approval
- Canada, 2008 · United States, 2001 · European Union, 2016
- Also known as
- Freon 218 · Octafluoropropane · Octafluorpropan · Oktafluorpropan · Perfluoropropane
- Code names
- DMP-115 · FC 218 · FS-069 · MRX-115
- Brand names
Resolves to
QYSGYZVSCZSLHT-UHFFFAOYSA-NSMILESFC(F)(F)C(F)(F)C(F)(F)FWhat you can answer from here — as of September 12, 2026
Which other approved drugs treat the same conditions as Perflutren, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account